Newton Biocapital
Avenue De Tervueren 273
1150 Woluwe-Saint-Pierre
BE
Newton Biocapital
Foundation date
07/04/2017
Sector
#InvestorSubsector
Newton Biocapital is a Venture Capital Fund incorporated in Belgium, focused on financing biotech and life science projects in the "core of Europe" (B, NL, D, F) and Japan for the prevention and treatment of chronic diseases.
Our approach as lead investor is to support promising start-up projects as well as neglected or undervalued late-stage projects, in order to mitigate the risks and to create investor value. The leadership team consists of specialists with long-standing management and investor experience who coach bio-entrepreneurs through the development stages of their projects.
Upcoming events
All events-
0411 '24
BIO-Europe® 2024 - 30th Annual International Partnering Conference
Event by: EBD Group -
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
1610 '24
FIGON Dutch Medicines Days
Event by: Hyphen Projects
Latest news
More news-
Scientists discover viral trapdoor blocking HIV and herpes
1 day ago
Read more
-
UZ Leuven and KU Leuven invest 14 million euro in new cell and gene therapy facility
Tuesday October 8th 2024
Read more
-
Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth
Monday October 7th 2024
Read more
Jobs
More jobs-
11/10/24
Flemish Brabant
Model based assessment of spraying techniques for sustainable crop protection (ref. BAP-2024-621)
Temporary
KU Leuven -
10/10/24
Flemish Brabant
Lab & Pilot researcher - Sustainable Chemical Processes (ref. ATP-2024-511)
Temporary
KU Leuven -
10/10/24
East Flanders
Smart Wound Dressings with Diagnostic and Antimicrobial Capabilities (ref. BAP-2024-663)
Temporary
KU Leuven
More info?
Ellen Telleir
Communication Coordinator